Palatin Technologies, Inc. (LON:0KF3)
6.50
-1.15 (-15.03%)
Oct 16, 2026, 5:12 PM GMT
Palatin Technologies Employees
Palatin Technologies had 25 employees as of June 30, 2026. The number of employees decreased by 4 or -13.79% compared to the previous year. That makes Palatin Technologies the 37,694th largest employer in the world and 763rd in the United Kingdom.
Employees
25
Change (1Y)
-4
Growth (1Y)
-13.79%
Revenue / Employee
397.50K GBP
Profits / Employee
-252.58K GBP
Market Cap
8.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 25 | -4 | -13.79% |
| Jun 30, 2025 | 29 | -1 | -3.33% |
| Jun 30, 2024 | 30 | -4 | -11.76% |
| Jun 30, 2023 | 34 | 1 | 3.03% |
| Jun 30, 2022 | 33 | 7 | 26.92% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IXICO | 79 |
| SkinBioTherapeutics | 41 |
| Oxford BioDynamics | 37 |
| Aptamer Group | 30 |
| Fusion Antibodies | 27 |
| OptiBiotix Health | 9 |
| Theracryf | 9 |
| Solvonis Therapeutics | 6 |
Palatin Technologies News
- 19 days ago - Palatin Technologies (PTN): Fiscal 2026 Revenue Inflection Comes With a Liquidity Test - AlphaStreet
- 20 days ago - Palatin Technologies Earnings Call Transcript: Q4 2026 - Transcripts
- 20 days ago - Palatin Technologies Earnings release: Q4 2026 - Filings
- 20 days ago - Palatin Technologies Annual report: Q4 2026 - Filings
- 20 days ago - Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - PRNewsWire
- 4 weeks ago - Palatin Technologies Slides: Corporate presentation - Filings
- 2 months ago - Palatin Technologies Slides: Corporate presentation - Filings
- 2 months ago - StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Newsfile Corp